125 related articles for article (PubMed ID: 16494627)
1. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
[TBL] [Abstract][Full Text] [Related]
2. Predictors identified for losses to follow-up among HIV-seropositive patients.
Lanoy E; Mary-Krause M; Tattevin P; Dray-Spira R; Duvivier C; Fischer P; Obadia Y; Lert F; Costagliola D;
J Clin Epidemiol; 2006 Aug; 59(8):829-835. PubMed ID: 16828676
[TBL] [Abstract][Full Text] [Related]
3. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.
Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Choisy P; Cochonat K; Fontier C; Guerroumi H; Ajana F; Chaud P; Yazdanpanah Y
Antivir Ther; 2009; 14(4):567-75. PubMed ID: 19578242
[TBL] [Abstract][Full Text] [Related]
4. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
[TBL] [Abstract][Full Text] [Related]
5. How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates.
Lanoy E; Lewden C; Lièvre L; Tattevin P; Boileau J; Aouba A; Chêne G; Costagliola D; ;
HIV Med; 2009 Apr; 10(4):236-45. PubMed ID: 19178591
[TBL] [Abstract][Full Text] [Related]
6. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
7. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
Piketty C; Selinger-Leneman H; Grabar S; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Mary-Krause M;
AIDS; 2008 Jun; 22(10):1203-11. PubMed ID: 18525266
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
Mary-Krause M; Billaud E; Poizot-Martin I; Simon A; Dhiver C; Dupont C; Salmon D; Roudiere L; Costagliola D;
AIDS; 2006 Aug; 20(12):1627-35. PubMed ID: 16868444
[TBL] [Abstract][Full Text] [Related]
13. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study.
Skiest DJ; Rubinstien E; Carley N; Gioiella L; Lyons R
Am J Med; 1996 Dec; 101(6):605-11. PubMed ID: 9003107
[TBL] [Abstract][Full Text] [Related]
14. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
Park WB; Choe PG; Kim SH; Jo JH; Bang JH; Kim HB; Kim NJ; Oh M; Choe KW
J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.
Karcher H; Omondi A; Odera J; Kunz A; Harms G
Trop Med Int Health; 2007 May; 12(5):687-94. PubMed ID: 17445136
[TBL] [Abstract][Full Text] [Related]
17. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
18. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
